Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of IMCB approved dividends

12/18/23 GEMA

Hard discounter chain B1 has launched its first STMs

12/18/23 MGNT

India lifts ban on diamond imports

12/18/23 ALRS

Sollers starts selling ST6 pickup trucks with gasoline engine

12/18/23 SVAV

Moscow Exchange connected all clients to the analog of Bloomberg terminal

12/18/23 MOEX

Shareholders of NovaBev approved dividends

12/18/23 BELU

UTair passenger traffic on airplanes in January-November increased by 9.4%

12/18/23 UTAR

MTS will develop a new format of retail stores

12/18/23 MTSS

MS-21 made the first time automatic landing under category IIIA

12/15/23 UNAC

Etalon Group shareholders approved the redomiciliation

12/15/23 ETLN